DDI Study of ASC41 in HV and the PK, Safety and Tolerability in Subjects With NAFLD.
Clinical trial NCT04845646 · COMPLETED
Trial details
- NCT number
- NCT04845646
- Sponsor
- Gannex Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-16
- Primary completion
- 2021-06-10
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.